Ultraviolet-Treated Red Blood Cell Vesicles Act as Potent Cancer Vaccine Adjuvants
Ultraviolet-irradiated erythrocyte microparticles deliver haem to dendritic cells, activating anti-tumour immune responses in preclinical models.
Ultraviolet-irradiated erythrocyte microparticles deliver haem to dendritic cells, activating anti-tumour immune responses in preclinical models.
A comprehensive review outlines how tumor-derived extracellular vesicles bridge minimally invasive cancer diagnosis, disease monitoring, and experimental therapeutic delivery.
A systematic review of twenty clinical trials reveals that adenovirus-based cancer vaccines reliably activate cellular immune responses with low severe ...
Researchers found that lipid nanoparticle delivery of interleukin-12 messenger RNA remodels the tumor microenvironment to boost personalized neoantigen cancer vaccine ...
Researchers developed an adhesive catalytic nanoreservoir targeting lung metastases and the spleen to capture tumor antigens and reprogram systemic antitumor ...
Researchers demonstrated that CD40-activated B cells loaded with CD66c peptides stimulate potent cytotoxic T-cell responses and synergize with checkpoint inhibitors ...
A comprehensive review details how solid tumor microenvironments, spatial and temporal heterogeneity, and emerging multi-agent therapies reshape clinical HER2 targeting ...
A scientific review highlights how antigen-presenting cells shape cancer immunotherapy responses while detailing tumor microenvironment barriers that currently limit therapeutic ...
Inhibiting PRMT5 induces retained intronic RNAs that form immunogenic double-stranded RNA structures and yield non-canonical peptide antigens capable of activating ...
MIT researchers have developed a modular bacteriophage-based nanoparticle platform that allows for the precise control of antigen density, enabling the ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine